Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 30, 2017 11:41 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Receives Approval for Male Fertility Product in Mexico

BATON ROUGE, LA--(Marketwired - May 30, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of...
May 23, 2017 08:30 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune CMO Begins Formulation Work on Tretinoin for Acute Promyelocytic Leukemia

BATON ROUGE, LA--(Marketwired - May 23, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of...
May 09, 2017 11:28 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Provides Corporate Update, Nearly 50 Drug Candidates in Pipeline or Being Negotiated

BATON ROUGE, LA--(Marketwired - May 09, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development...
May 03, 2017 12:23 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Completes Enrollment in Phase 1 Trial of ProscaVax for Prostate Cancer

BATON ROUGE, LA--(Marketwired - May 03, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of...
April 26, 2017 09:37 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune, AqVida Partner for Commercializing Cancer and Other Generic Drugs in Mexico

BATON ROUGE, LA--(Marketwired - April 26, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development...
April 20, 2017 09:31 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Licenses Tretinoin for the Treatment of Acute Promyelocytic Leukemia Throughout Mexico, Central and Latin America

BATON ROUGE, LA--(Marketwired - April 20, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development...
April 18, 2017 15:10 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Prepares Submission Seeking Marketing Approval for Anti-D Immunoglobulin in Mexico

BATON ROUGE, LA--(Marketwired - April 18, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development...
March 30, 2017 09:00 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune and Gem Pharmaceuticals Finalizing Partnership Terms to Develop New Cancer Drug for Mexico, Central and Latin America Markets

BATON ROUGE, LA--(Marketwired - March 30, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development...
March 27, 2017 08:30 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Sales of Bekunis(R) and Cirkused(R) Exceed Forecast by 164 Percent in First Six Months on Market

BATON ROUGE, LA--(Marketwired - March 27, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development...
March 20, 2017 10:07 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Announces Term Sheet to Acquire Norepinefrine from Teva Pharmaceuticals in Mexico

BATON ROUGE, LA--(Marketwired - March 20, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development...